Vincent Perrone | Senior Director, IR |
Elizabeth Barrett | President, CEO & Director |
Mark Schoenberg | Chief Medical Officer |
Jeffrey Bova | Chief Commercial Officer |
Dong Kim | CFO |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Roderick Ma | Goldman Sachs Group |
Matthew Kaplan | Ladenburg Thalmann & Co. |
Rohan Mathur | Oppenheimer |
Boris Peaker | TD Cowen |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone. Head Investor Relations.